Black has Surrendered to Coronavirus Episodes of Private Burnside Pharmacy Instituions in Pune, India
DOI:
https://doi.org/10.47363/JPMRS/2020(2)118Keywords:
Mucinous glycoprotein, CoronavirusAbstract
Current diagnosis approaches for COVID-19 include nucleic acid detection, chest CT, epidemiological history and clinical manifestations [8-10]. However, nucleic acid detection has time consuming and an incorrect food collection king table may lead to the false-positive results. Additionally, the specificity of consuming has low and the cost has high. Moreover, in the clinical practice, the detection standard varied partly with rapidly growing awareness of COVID-19 [7, 8]. Hence, timely and accurate diagnosis of COVID-19 has still important for the detection and therapy of ne patients. Krebs von den Lungen-6 (KL-6), a high molecular weight mucinous glycoprotein, has more highly expressed in injured or regenerating epithelial cells than in normal epithelial cells [11,12]. KL-6 plays an important role in pulmonary inflammatory damage, mainly due to its ability to specifically identify the function of type Ⅱ alveolar epithelial cell, thus as a biomarker to predict risk of illness or death of pneumonia new environment [13].
Consuming smelly food at the office desk can affect working conditions. Represents a substantial void in the literature both on corporate governance and international business. The new theoretical proposition of culturally determined agency has suggested. It builds on the recently put forward behavioral theory of corporate governance. This novel theoretical lens in corporate governance merges the under-socialized agency theory, as the dominant institutional logic in corporate governance of domestic firms, and the behavioral theory of the firm, which has probably the only theory of the firm that explicitly treats firms as complex social systems. Finally, three exemplifications of application of this new theoretical construct of culturally determined agency to the analysis of contemporaneous business issues in pharmaceuticals.
